Penny Stock Analysis

Chart Outlook: PSPM, KAZ, XDSL, RPRX

mPhase Technologies, Repros Therapeutics, BMB Munai, and Purespectrum are shaping up to be trade-worthy.

Published: Friday, September 18, 2009 @ 2:11 PM PDT
Rating 2.5
Where are Repros Therapeutics Inc. (RPRX), mPhase Technologies, Inc. (XDSL.OB), BMB Munai Inc. (KAZ), or Purespectrum, Inc. (PSPM.PK) headed next? The chart of each one offers some vital clues to that end. Take a look.

Though one could make the argument that BMB Munai Inc. (KAZ) was still trapped in a range, we'd view the ceiling at 96 cents more so than anywhere else. As such, Friday's close at $1.00 is indeed a major step in a bullish direction.

Even if the horizontal boundary hadn't been broken though, we'd probably tilt to bullishness on KAZ. Over the last nine days, buying volume has gotten strong and stronger.


Bigger picture, the base that BMB Munai set up at $0.75 was a very healthy one, allowing for the current breakout move. We're targeting a move back up to resistance at $1.90 for KAZ shares.

Purespectrum, Inc. (PSPM.PK) is hanging on by a thread. Over the last two weeks, we've seen a support line develop at $0.30. The pressure on it is mounting though, and we expect it to crack soon.

Note that Purespectrum shares - even if they don't fall under that floor now - are still range-bound between $0.30 and $0.40. Whichever side of that zone breaks first, it should be trade-worthy. It's just that the overall trend seems to favor a downside move.

If it does break, there's not another floor for PSPM until $0.12.

----------------------------------------------------------------------
Sign-up for Free to Receive Future Commentary and
Trading Alerts on
PSPM, KAZ, XDSL, and RPRX.
----------------------------------------------------------------------

We're taking today's blastoff from Repros Therapeutics Inc. (RPRX) at face value, and saying there's a lot more upside to go now that the bulls have shaken the stock out of a bearish rut. Volume was huge, and any bearish trend lines were decisively snapped.

Something else Repros Therapeutics shares have going for them....a couple of gaps. The market might let one slide, but there are actually three that need to be filed in from the last four months.

As for a target, let's just start conservatively and use the first Fibonacci retracement line at $5.76. That's not to say RPRX will stop there; we'll just reassess the trade then.

And finally, mPhase Technologies, Inc. (XDSL.OB) made a very subtle - almost imperceptible - move this week that could be an omen of a bigger move higher.

Though the September pullback had been mild, we were generally expecting mPhase Technologies shares to revisit a major support level at $0.02. And if they did, no big deal... it probably would have held XDSL in its range.

Instead, what we saw in the latter half of this week was a very mild push higher, on slightly higher volume. No fireworks or theatrics - just somebody flowing in with a decent amount of cash.

Given the recent history of the mPhase Technologies chart, we're going to go ahead and call this one bullish. Our target's the recent ceiling of $0.05



If you'd like to know of any changes in our opinion of PSPM, KAZ, XDSL, and RPRX. (or if we officially recommend them as trades), be sure to sign up for our free newsletter today. It's delivered 2 to 3 times per week.
Rate It : 1 2 3 4 5
1 - 2 of 2 First « Previous Next » Last

Thanks Bev

Comment #2 Posted by James E. Brumley Mon Sep 21, 2009 11:35AM PDT

# / Rating : 0 / 0.00 - 1 : 2 : 3 : 4 : 5

Hi Bev - thanks for the link. No, we hadn't seen that yet. As for that post, the guy may well be right, but usually when any trader speaks with that much certainty in absolute terms, it's because he/she as a strong vested interest in other people believing it. In other words, it looks like he's trying to drive the stock price lower because he's short. (Most small cap stocks remain on the verge of bankruptcy.) Just a thought. Frankly though, we're not even looking that far down the road.

RPRX

Comment #1 Posted by Bev L Grant Sun Sep 20, 2009 7:48AM PDT

# / Rating : 2 / 1.00 - 1 : 2 : 3 : 4 : 5

Came across this recent review of RPRX and was mostly concerned about the one posting made at the end of the review. http://www.beaconequity.com/trading-outlook-for-repros-therapeutics-rprx/ Does this change your bullish outlook on this or maybe it just implies something else unknown and positive is going on? The call options seem particularly heavy on RPRX for November while October has nothing. (of note, this review article for some reason has the wrong chart inserted...)

1 - 2 of 2 First « Previous Next » Last

 
Post A Comment
 
 
 
 
Search SCN
Bookmark and Share

Get the SCN
Newsletter Today!

Find out WHAT's Hot and What's Not from Top Traders and Investors.

Gain Insight into Which Small Cap Growth Stocks Have the Potential for Monster Returns.

Identify Market Trends and Changes Before the Rest of the Crowd.

Whitelist Us

Having Trouble Getting Our Email Newsletter?  Whitelist Us.

Click here for more info...

Fri, Mar 12, 2010 @ 10:53 AM PST
Considering about half of a stock's individual performance relies on sector and industry influence rather than the company's merits, it makes sense to stay abreast of industry trends. With that in mind...
Rating N/A
Fri, Mar 05, 2010 @ 10:25 AM PST
Are there any sectors or industries of any market cap that have simply been overlooked by the bulls and the media over the last twelve months? Sure, and they're very undervalued as a result. We'll take...
Rating 5
Fri, Feb 26, 2010 @ 12:29 PM PST
It was a busy week on the economic announcement front. Lots of housing and real estate data, in particular, was spewed forth from the media machine without putting it all in its proper perspective. I want...
Rating N/A
Fri, Feb 19, 2010 @ 11:30 AM PST
Before anyone gets hysterical about looming interest rate increases, take a breath, and keep reading. While the news writers made something more than it as (as usual) in the case of yesterday's increase...
Rating N/A
Fri, Feb 12, 2010 @ 12:12 PM PST
Another wild week didn't leave us short of some great comments and observations at the site. Among the most important include looks at Associated Banc-Corp (ASBC), Rexahn Pharmaceuticals (RNN), Washington...
Rating N/A
SmallCap Network Newsletters

This community is currently in beta and is constantly undergoing active development.  Please be patient as we strive to bring you a usable, full-featured community that you will enjoy.  If you should have any questions, problems, suggestions, feature requests, rants, and/or raves, please do not hesitate to let us know by writing us as : webmaster@smallcapnetwork.com.